Literature DB >> 20367506

Predictive value of clinical and laboratory indices at first assessment in women referred with suspected gestational hypertension.

Dilly O C Anumba1, Karen Lincoln, Stephen C Robson.   

Abstract

OBJECTIVE: To establish the predictive value of tests in women referred with suspected gestational hypertension (GH) for preeclampsia and other adverse outcomes.
METHODS: A retrospective analysis of a database of clinical laboratory records of 560 women referred to day care was carried out for the prediction of adverse fetal and maternal outcomes.
RESULTS: Gestational age at first presentation < 32 weeks, gestation-standardised blood pressure parameters and serum uric acid were more predictive of the development of preeclampsia, delivery before 34 weeks, severe hypertension and fetal growth restriction than absolute values. Alanine transaminase and platelet counts were not predictive.
CONCLUSION: The predictive value of blood pressure and serum uric acid are improved when they are standardised as z-scores but there appears to be no value to assessing other laboratory indices when women first present with GH without proteinuria.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20367506     DOI: 10.3109/10641950902968635

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  8 in total

1.  Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Zeynep Alpay Savasan; Juan Pedro Kusanovic; Giovanna Ogge; Eleazar Soto; Zhong Dong; Adi Tarca; Bhatti Gaurav; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-09

2.  Description of a strong relationship among total cell-free DNA levels, LDH values, AST values and platelet count in patients with HELLP syndrome.

Authors:  Pablo Stiefel; María L Miranda; Hada Macher; Luis M Beltran-Romero; Rocio Muñoz-Hernandez
Journal:  Hypertens Res       Date:  2017-03-23       Impact factor: 3.872

3.  Uric acid: is it time to give up routine testing in management of pre-eclampsia?

Authors:  Vikram Sinai Talaulikar; Hassan Shehata
Journal:  Obstet Med       Date:  2012-03-29

4.  Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Josef M Cortez; Athina Pappas; Adi L Tarca; Piya Chaemsaithong; Zhong Dong; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-08

5.  Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study.

Authors:  Radwa Marawan AbdelHalim; Dalia Ibrahim Ramadan; Reham Zeyada; Ahmed Soliman Nasr; Iman Atef Mandour
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

Review 6.  Hypertension in pregnancy: natural history and treatment options.

Authors:  L Foo; J Tay; C C Lees; C M McEniery; I B Wilkinson
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

7.  Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial.

Authors:  Laura A Magee; Peter von Dadelszen; Joel Singer; Terry Lee; Evelyne Rey; Susan Ross; Elizabeth Asztalos; Kellie E Murphy; Jennifer Menzies; Johanna Sanchez; Amiram Gafni; Andrée Gruslin; Michael Helewa; Eileen Hutton; Shoo K Lee; Alexander G Logan; Wessel Ganzevoort; Ross Welch; Jim G Thornton; Jean Marie Moutquin
Journal:  Acta Obstet Gynecol Scand       Date:  2016-04-07       Impact factor: 3.636

8.  Effectiveness and safety of 1 vs 4 h blood pressure profile with clinical and laboratory assessment for the exclusion of gestational hypertension and pre-eclampsia: a retrospective study in a university affiliated maternity hospital.

Authors:  Elizabeth Anne McCarthy; Thomas A Carins; Yolanda Hannigan; Nadia Bardien; Alexis Shub; Susan P Walker
Journal:  BMJ Open       Date:  2015-11-18       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.